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Abstract
Background: Fertilization, cell division and embryo development depend on genomic contributions from male
and female gametes. We hypothesize that teratozoospermic sperm influences early embryo development and
embryo compaction.
Methods: We conducted a retrospective analysis of embryos derived from intracytoplasmic sperm injection (ICSI)
cycles. Two hundred thirty-five consecutive ICSI cycles were included in the study; all treatment was provided at
the Cleveland Clinic Fertility Center. Patient cycles were divided by sperm morphology based on Kruger’s strict
criteria: Group A, embryos where teratozoospermic sperm (0-2% normal) were used for ICSI and Group B, embryos
where dysmorphic sperm (5-13% normal) were used for ICSI. All cycles analyzed were of patients doing day 3
embryo transfers. Outcome measures assessed included pronuclear (PN) pattern, syngamy, early cleavage, cell
number, rate of compaction and blastulation of embryos left in culture and not transferred on day 3.
Results: A total of 1762 embryos were analyzed. PN patterns were similar in Group A and Group B embryos. No
differences were noted in syngamy, cleavage, cell number or blastulation rate. Studying the development of
embryos in culture after day 3 transfer revealed a difference in the timeline for compaction. By day 4, 25% of
Group A embryos had compacted compared to 36% in Group B (P = 0.0007). There was no difference found
between Group A and Group B embryos in regards to blastulation.
Conclusions: We did not find an association between sperm morphology and clinical outcomes. The impact of
teratozoospermia may be masked in ICSI cycles where fertilization, implantation rate and clinical pregnancy rate are
the primary outcome measures. However, by examining the timeline of development, we were better able to
discern a potential paternal effect at critical transition points from fertilization through activation.
Background
Intracytoplasmic sperm injection (ICSI) has allowed for
the use of extremely teratozoospermic sperm specimens
for in vitro fertilization (IVF). Fertilization by direct
injection of the sperm into the oocyte circumvents the
usual process for combining male and female genomes.
While oocytes supply the cytoplasmic environment
necessary for sperm microtubule function, the sperm is
responsible for the centrosome, which gives rise to
microtubules [1]. Human reproduction involves several
critical steps including fertilization of the oocyte,
syngamy of male and female pronuclei, cleavage, geno-
mic activation, blastulation and finally implantation. If
these developmental processes are hindered, the embryo
will arrest and a viable pregnancy will not be achieved.
Paternal effect on early embryonic development and
subsequent fertility is an area of great interest. Abnor-
mal sperm morphology can be an indicator of one or
more other defects including damaged DNA, chromoso-
mal abnormalities and centriole deficiency [2,3]. Data
suggests that morphologically abnormal sperm and/or
DNA fragmented sperm have a negative impact on ferti-
lization and embryo quality, even when ICSI is per-
formed [4-7]. Evidence of a strong paternal effect on
early embryonic development and blastocyst formation
in vitro has been reported [8]. The relationship between
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sperm morphology and IVF/ICSI cycle outcomes still
however remains controversial. In a more recent study,
French et al. observed that severe teratozoospermia had
no effect on blastulation [9].
The earliest morphological assessment of embryos in the
laboratory occurs at the time of fertilization check. The
presence of two pronuclei (PN) signals the combining of
male and female genome in the developing zygote [10].
Pronuclear morphology and arrangement of nucleolar pre-
cursor bodies (NPB) provide the earliest information on
sperm:egg interaction. The NPB number, size and distri-
bution have been correlated to embryo quality, develop-
ment and IVF outcome [10-15]. Specific PN morphology
patterns have also been associated with an increase in
implantation and pregnancy rates [11,12,14-18]. Another
critical point in development is embryonic genomic activa-
tion, when genes from maternal genome are no longer
expressed [19]. During in vitro culture this is marked by
signs of embryonic compaction usually observed on day 3
or day 4 of culture [20,21].
In this investigation we compare embryonic develop-
ment from zygote to blastocyst in patients with severe
teratozoospermia to those with less severely dysmorphic
sperm. We postulate that this may be a good model to
study paternal contribution to early embryonic develop-
ment because with severe teratozoospermia, chromoso-
mal anomalies and inherent DNA damage may interfere
with early steps of zygote formation, syngamy, cleavage,
genomic activation and blastulation. These data will also
allow us to better understand the contribution of sperm
morphology assessment to outcomes with ICSI.
Methods
Patients
We retrospectively analyzed embryo morphology along
with IVF cycle outcomes. Embryos were generated by
ICSI, using sperm from patients with varying levels of
dysmorphic morphology, including teratozoospermia.
This study was conducted under an approved IRB and
involved analysis of data collected from patients under-
going treatment at the Cleveland Clinic Fertility Center
between June 2006 and June 2008. All patients included
were < 37 years of age to minimize advanced maternal
age factors. Cycles were further divided into subgroups
based on sperm morphology assessment using Kruger’s
strict criteria. Two subpopulations were created, Group
A consisted of 110 patients including 901 embryos from
severely teratozoospermic sperm (0-2% normal mor-
phology), and Group B consisted of 125 patients includ-
ing 861 embryos from less dysmorphic sperm (5-13%
normal forms). Patients with sperm morphology not fall-
ing into Group A or Group B were excluded. Cycles
with insufficient sperm (< 1 million/ml) were excluded.
Sperm morphology assessment and preparation for ICSI
Sperm specimens were evaluated for total sperm count,
motility, progression and sperm morphology during IVF
semen analysis. Sperm were stained using Diff-Quik
(Dade Behring, Newark, Delaware) and graded on the
basis of Kruger’s strict criteria [22]. Percent normal
forms were determined for each specimen after scoring
100 sperm. Uniformity of grading in the laboratory was
routinely monitored for inter technician variation. Den-
sity gradient centrifugation over a 90% layer of Isolate
(Irvine Scientific, Santa Ana, California) was used to
prepare sperm for ICSI.
IVF protocol
Patients were down regulated using a long luteal leupro-
lide acetate (Lupron; TAP, Pharmaceuticals, Lake Forest,
Illinois) protocol, followed by gonadotrophins for ovula-
tion induction. Ultrasound guidance was used to trans-
vaginally aspirate and collect oocytes. Under an oil
overlay, ooctyes were cultured in microdrops of human
tubal fluid (HTF) (LifeGlobal, Guilford, Connecticut)
supplemented with human serum albumin (10 mg/mL)
(Cooper Surgical Inc., Trumball, Connecticut). Culture
dishes were incubated at 37°C with 5.5% CO2. ICSI was
performed on mature oocytes 3-4 hours after retrieval.
Sperm selection for ICSI was based on identification of
the most normal looking sperm in the available sperm
specimen that also exhibited some motility. Any observed
variations between Group A and Group B embryos were
therefore most likely reflective of intrinsic differences in
the initial sperm specimen since the methodology for
sperm selection did not differ between Group A and
Group B. Fertilization was checked 18-20 hours after
oocyte injection. Zygotes were classified into seven mor-
phologic patterns based on number and distribution of
nucleoli within the pronucleus, consistent with Kruger’s
strict criteria. Fertilized oocytes were cultured individu-
ally until day 3 in microdrops of HTF supplemented with
10% Synthetic Serum Substitute (SSS) (Irvine Scientific,
Santa Ana, California).
Embryo development was monitored daily. All patients
included had a day 3 transfer. Day 3 embryo grading
was based primarily on cell number, percent fragmenta-
tion and signs of increased cell:cell adherence or com-
paction [23]. Pronuclear pattern, syngamy and early
cleavage were also given consideration in evaluating the
embryo. Non-transferred embryos of good quality (6-
8 cells, < 15% fragmentation) were cryopreserved. All
other embryos remained in culture for an additional 2-3
days; blastocysts of good quality were subsequently fro-
zen on either day 5 or 6. Embryo transfer was per-
formed under ultrasound guidance using a Wallace
catheter. Pregnancy testing was done 15-16 days after
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the embryo transfer. Clinical pregnancy was confirmed
by the presence of a fetal heart on ultrasound at
6-8 weeks of pregnancy.
Data collection and analysis
Patient embryos were grouped on the basis of sperm
morphology used for the ICSI procedure, Group A ver-
sus Group B. The primary outcome measures included
fertilization rate after ICSI, number of embryos trans-
ferred, rate of blastocyst formation, implantation rate
and clinical pregnancy. The disposition of embryos
derived from sperm samples with severe teratozoosper-
mia (Group A, 0-2% normal) was compared to those
embryos created from sperm with less severe dysmorph-
isms (Group B, 5-13% normal).
Two hundred fifty-six transfers were performed on day
3. In order to compare how poor sperm quality influ-
ences embryo development, we grouped patients accord-
ing to degree of sperm dysmorphisms and analyzed PN
patters, syngamy achievement, presence of early cleavage,
cell number at day 2 and day 3, rate of compaction, rate
of blastulation and embryo destiny (i.e. whether the
embryo was transferred, frozen or discarded).
Fertilization rates were calculated by dividing the
number of oocytes that fertilized normally by the num-
ber of oocytes subjected to the ICSI procedure. PN mor-
phology assessments were recorded per embryo at the
time of fertilization check, 18-20 hours after ICSI was
performed. Blastulation rate was calculated by dividing
the number of embryos that blastulated by the number
of embryos in culture past day 3. The implantation rate
was calculated by dividing the total number of fetal
hearts by the total number of embryos transferred. Clin-
ical pregnancy was determined by the presence of a fetal
heart on ultrasound at 6 weeks.
Means and standard deviations were used to summar-
ize continuous indices such as patient age, oocytes ferti-
lized, number of embryos transferred and sperm
concentration. Pronuclear pattern, syngamy and early
cleavage and development were expressed as a percen-
tage of embryos examined. Chi-square test and the stu-
dent T-test were applied as appropriate to compare
summary data as well as development rates of embryos.
PN patterns were further evaluated using Cochran-Man-
tel-Haenszel (CMH) statistics to determine significance
between the seven patterns observed and the outcome
measures of interest. P values less than 0.05 were con-
sidered to be statistically significant.
Results
A total of 1762 embryos derived from 258 oocyte retrie-
vals of patients who fit the criteria for inclusion in our
study. The 235 women in this study were between 24
and 36 years of age. Embryonic development was com-
pared between embryos derived from sperm samples
with severe teratozoospermia, Group A defined as
embryos where ICSI was performed with sperm 0-2%
normal forms, and less dysmorphic samples, Group B
with embryos where ICSI was performed with sperm
5-13% normal forms. This data set allowed us to exam-
ine the effect of severe teratozoospermia versus dys-
morphic sperm on embryo development including
cleavage, compaction and the ability of embryos to
blastulate.
Fertilization rate was not affected by the morphology
of the initial sperm specimen. Moreover implantation
and clinical pregnancy rates were like-wise unaffected by
sperm morphological characteristics. The clinical preg-
nancy rate for day 3 transfer patients in Group A was
55% versus 53% in Group B (Table 1).
The influence of severe teratozoospermia at the earliest
stage of zygote development, i.e. formation of pronuclei,
was investigated. The pronuclear patterns observed in
embryos transferred, frozen or discarded were compared
between Group A and Group B (Table 2). Regardless of
sperm type, the majority of zygotes exhibited 3-7 large
nucleoli that were polarized and aligned (Pattern OP).
The second most prevalent arrangement observed was
Pattern 2. Interestingly, Patterns 4 and 5, usually asso-
ciated with poorer embryo potential [10] were not repre-
sented at a higher frequency in embryos arising from
teratozoospermic sperm specimens, P > 0.05.
Table 3 compares benchmarks of in vitro development
of embryos in Group A and Group B. Syngamy and early
cleavage proceed similarly in both groups of embryos.
When comparing cell number, 64% of Group A embryos
were 6 cells or greater as compared to 66% in Group B.
Embryonic blastulation was also not affected by morphol-
ogy of sperm in the original specimen. With day 3 trans-
fer cycles, ‘spare’ embryos were cultured for an additional
2-3 days. We did not see a significant negative impact
from sperm morphology on blastocyst formation.
Embryo utilization, i.e. percentage of zygotes transferred
and frozen in the two groups was compared. The percen-
tages of embryos either frozen or transferred were not
significantly different between Group A and Group B.
Severe teratozoospermia was not associated with a differ-
ence in overall embryo utilization.
Most notable was observations of embryonic compac-
tion between Group A and Group B (Table 3). The per-
centage of embryos exhibiting compaction was analyzed
on day 4 of culture. We found that significantly fewer
embryos from Group A had undergone compaction
compared to Group B embryos (P = 0.0007). Interest-
ingly, although slower to compact, by the end of the
culture interval (day 5/6) Group A blastulation was 34%
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compared to Group B 38% blastulation, P > 0.05; blastu-
lation rates were not significantly different even though
compaction rates showed a delay in Group A.
Discussion
The focus of the study was to characterize early devel-
opment in embryos derived from severely teratozoosper-
mic specimens and compare the pattern of development
to embryos derived from less dysmorphic sperm. Such
observations might help us better understand paternal
contribution to embryo development in vitro. Our data
suggested that embryonic compaction, an early indica-
tion of genome activation, was the only parameter sig-
nificantly influenced by sperm morphology. It appeared
that embryos derived from teratozoospermic sperm
were slower to compact, but by day 5/6 of culture, blas-
tulation rates were similar in the two groups. We also
noted severe teratozoospermia did not impair implanta-
tion or clinical pregnancy rates, which is in concordance
with findings from Hotaling et al’s 2010 meta-analysis of
teratozoospermia and clinical pregnancy after IVF [24].
The impact of overall sperm morphology assessment
on IVF outcomes, especially in ICSI cases, has been the
focus of many idiopathic infertility studies but remains
controversial. Kruger et al. proposed that morphological
classification of sperm based on strict criteria can be
used to predict fertilization outcomes [25]. Kruger’s strict
criteria states sperm specimens with less than 14% nor-
mal forms have decreased ability to fertilize. Others have
proposed further grouping on the basis of sperm mor-
phology into good prognosis 4-14% normal forms and
poor prognosis < 4% normal forms [7,26,27]. Our study
concentrated on embryos derived from two populations
of suboptimal sperm. We specifically chose to examine
embryos derived from extremely teratozoospermic sperm
specimens with 0-2% normal forms and 5-13% normal
forms. This was done in order to accentuate differences
between the groups. Using 5-13% normal forms as cut-
off for dysmorphic sperm and eliminating the middle
group with 3-4% normal forms, we excluded specimen
bordering Group A and Group B. While these sperm
groupings may be unconventional, our aim was to study
Table 1 Patient data
Group A Group B
Number of patients 110 125
Number of transfers 121 135
Average age 31.88 ± 2.739 32.59 ± 2.64
Average oocytes per retrieval 12.99 ± 5.78 13.23 ± 6.84
Average mature oocytes per retrieval 9.93 ± 4.98 9.21 ± 4.37
Number of embryos 901 861
Fertilization rate 79% 78%
Average number of cells in transferred embryos, observed on day 3 7.50 ± 1.35 7.34 ± 1.50
Average embryos transferred 2.14 ± 0.39 2.12 ± 0.44
Implantation rate 33% 33%
Clinical pregnancy rate 55% 53%
Group A: ICSI was done using severe teratozoospermic sperm, 0-2% normal morphology, Group B: ICSI was done using dysmorphic sperm, 5-13% normal
morphology. P values for data above all > 0.05.
Table 2 PN pattern in embryos






























OP 50% 54% 46% 18% 45% 43% 51% 20%
O 14% 15% 10% 3% 11% 12% 10% 4%
1 2% 1% 2% 1% 2% 2% 2% 1%
2 19% 16% 22% 6% 20% 24% 22% 8%
3 0% 1% 3% 1% 4% 2% 1% 0%
4 8% 9% 12% 4% 9% 11% 9% 1%
5 6% 4% 5% 1% 9% 7% 5% 2%
Group A: ICSI was done using severe teratozoospermic sperm, 0-2% normal morphology, Group B: ICSI was done using dysmorphic sperm, 5-13% normal
morphology. P values for data above all > 0.05.
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the impact of poor sperm morphology on embryo devel-
opment and not necessarily to compare good sperm mor-
phology to poor sperm morphology.
A direct correlation between abnormal sperm morphol-
ogy and sperm function has been difficult to establish. A
meta-analysis studying outcomes with conventional IVF
strongly supports the diagnostic value of critical morphol-
ogy assessment in sperm specimens [28]. Specifically the
type of sperm morphological defect may be correlated to
whether there is a connection between morphology and
chromosome abnormalities. Furthermore, FISH studies
suggest a greater frequency of aneuploidy with certain
forms of teratozoospermia such as globospermia,
enlarged head syndrome and polymorphic teratozoosper-
mia [29]. Other reports contradict these finding and
claim abnormal sperm morphology is a poor predictor of
cycle outcomes [30-32].
Sperm DNA fragmentation and a correlation with
sperm morphology is also relevant when investigating
teratozoospermia and embryonic development. While
the embryo may be able to repair low levels of DNA
damage introduced by the sperm nucleus [33,34], if the
sperm DNA is damaged beyond repair, complete and
accurate transmission of genetic information to the
embryo may become compromised. In addition, amor-
phous sperm heads have been associated with an ele-
vated degree of DNA fragmentation [35]. Using
intracytoplasmic morphologically selected sperm injec-
tion (IMSI) to choose sperm has shown abnormal nuclei
usually have a lower fertility potential than sperm with
normal nuclei [36].
With ICSI, the normal barriers to fertilization are
transcended allowing even the most teratozoospermic
specimens to successfully create a zygote. DNA frag-
mentation in morphologically normal looking sperm has
also been shown to negatively impact on ICSI cycle out-
comes and embryo quality [6]. Thus sperm morphology
may not by itself be an accurate predictor of the compe-
tency of the DNA within the sperm itself, nor chromo-
somal status. Paternal effect on early embryogenesis is
often overlooked, yet the sperm centrosome is directly
involved in forming the sperm aster and organizing the
mitotic spindle. While human oocytes do not contain
centrioles, the sperm contains two. Microtubules, which
extend from centrioles, are responsible for proper pro-
nuclei movement and fusion [37], as well as pronuclei
alignment [38]. Centriolar defects, or an absence of cen-
trioles, are most often associated with compromised
sperm [39,40] and may affect microtubule formation
[41]. We therefore had expected to see differences in
PN patterns between Group A and Group B.
The earliest stage post-fertilization to assess the impact
of sperm on zygote development is pronuclear formation.
Pronuclear morphology and nucleolar organization have
been correlated to embryo quality [10,42]. Our expecta-
tion was that if teratozoospermia was associated with an
increase in DNA defects within the sperm, or centriolar
defects, pronuclear patterns would be negatively affected.
Zygotes with abnormal PN patterns such as those with
less than 3 NPB in at least one PN (Pattern 4) or those in
which there are both polarized and non-polarized NPB
(Pattern 5), have been suggested to have lower pregnancy
potential [13]. These zygotes with abnormal PN patterns
have further been reported to more frequently result in
chromosomally abnormal embryos than those with nor-
mal PN patterns [43]. With ICSI cases, the use of terato-
zoospermic sperm specimens did not appear to increase
the percentage of abnormal PN patterns. The percentage
of zygotes with polarized NPB (Pattern OP) believed to
be predictive of good embryo quality was similar between
the two sperm test groups, Group A and Group B.
Human embryo genomic activation occurs on or
around day 3. Expression of zygote transcripts has been
shown to begin at approximately the 4 to 8 cell stage
[19,44]. An early morphologic indicator of embryonic
genome activation is compaction, the increase of cell:cell
adherence, also occurring around the 8-cell stage [45].
Examining the day 4 data collected showed a delay in the
timing of compaction in the cohort of embryos derived
from Group A sperm, Table 3. A greater percentage of
embryos compacted by day 4 in Group B, although the
final blastulation rates between sperm groups remained
similar. One potential explanation for the significant
decrease in compaction rates we observed is that there is
delayed genome activation in the Group A embryos
Table 3 Embryo development and utilization data
Group A Group B P value
Total embryos 901 861
Embryonic development, D1-D3
Syngamy (at 25 hours) 39% 34% 0.0516
Early cleavage (at 25
hours)
9% 9% 1.0000
Cleavage (D2 at 48 hours) 98% 99% 0.3833




Embryos compacting (D4) 25% 36% 0.0007
Blastulation
Total embryos in extended
culture
471 432
Overall blastulation rate 34% 38% 0.3297
Overall utilization
Embryos transferred 28% 30% 0.3865
Embryos frozen 34% 36% 0.3401
Group A: ICSI was done using severe teratozoospermic sperm, 0-2% normal
morphology, Group B: ICSI was done using dysmorphic sperm, 5-13% normal
morphology. Yates-corrected Chi2 P values given above.
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possibly attributable to the severe teratozoospermia in
the specimens used for ICSI. Compaction occurs as a
result of an intricate series of events dependent upon
many factors including but not limited to E-cadherin and
catenein complexes, junction components, protein kinase
C and the PAR complex [20,45-47]. With so many vari-
ables involved, our observation correlating compaction
rates with genomic activation would greatly benefit from
further studies.
In conclusion, we did not find an association between
sperm morphology and clinical outcomes. The impact of
teratozoospermia may be masked in ICSI cycles where
fertilization, implantation rate and clinical pregnancy are
the primary outcome parameters measured. Through
sequential analysis of embryos from fertilization through
blastulation we hoped to achieve a better understanding
of paternal influence on the different stages of embryonic
development. Contrary to our expectations, we did not
observe an early paternal effect at the point of pronuclear
formation nor an effect on blastulation rate. We did how-
ever find a measurable difference in compaction, which
we feel strongly warrants further investigation into the
paternal effect on embryonic activation. A detailed step-
wise analysis of morphology and the timeline of develop-
ment in embryos arising from severely teratozoospermic
sperm versus sperm with less dysmorphisms has not
been previously reported. Design of a prospective study
with day 5 transfers may be extremely valuable in further
studying paternal effect on zygotic activation.
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